Male preponderance in chronic lymphocytic leukemia utilizing IGHV 1-69 [1]

Leukemia

Volumn 21, Issue 12, 2007, Pages 2537-2538

  Walewska, R ^a   Majid, A ^a   Davis, Z ^b   Dusanjh, P ^a   Kennedy, D B J ^c   Oscier, D G ^b   Dyer, M J S ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^c University Hospitals   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN HEAVY CHAIN 1-69; RNA; UNCLASSIFIED DRUG;

BLOOD SAMPLING; CHROMOSOME 11Q; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENE REARRANGEMENT; GENETIC ASSOCIATION; GENETIC DATABASE; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOGLOBULIN VARIABLE REGION; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEX DIFFERENCE; SEX ROLE;

EID: 36349020243     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404836     Document Type: Letter

References (7)

1. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006; 107: 265-276.
2. Molica S. Sex differences in incidence and outcome of chronic lymphocytic leukemia patients. Leuk Lymphoma 2006; 47: 1477-1480.
3. Cartwright RA, Gurney KA, Moorman AV. Sex ratios and the risks of haematological malignancies. Br J Haematol 2002; 118: 1071-1077.
4. Oscier DG, Gardiner AC, Mould SJ, Glide S, Davis ZA, Ibbotson RE et al. Multivariate analysis of prognostic factors in CLL: Clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002; 100 1177-1184.
5. Ghiotto F, Fais F, Valetto A, Albesiano E, Hashimoto S, Dono M et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest 2004; 113: 1008-1016.
6. Stamatopoulos K, Belessi C, Moreno C, Boudjograh W, Guida G, Smilevska T et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood 2007; 109: 259-270.
7. Catera R, Hatzi K, Chu CC, Herve M, Meffre E, Ferrarini M et al. Polyreactive monoclonal antibodies synthesized by some B-CLL cells recognize specific antigens on viable and apoptotic T Cells. Blood 2006; 108: 2813.